Lattice Capital Management’s Eli Lilly LLY Stock Holding History

Lattice Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,218	Closed	-$1.31M	–	20
2025 Q4	$1.31M	Hold	1,218	–	–	1.84%	13
2025 Q3	$929K	Hold	1,218	–	–	0.89%	13
2025 Q2	$949K	Buy	1,218 +200	+20%	+$155K	1.05%	13
2025 Q1	$841K	Hold	1,018	–	–	0.86%	12
2024 Q4	$786K	Buy	+1,018	New	+$843K	0.65%	15
2024 Q2	–	Sell	-3,918	Closed	-$3.05M	–	34
2024 Q1	$3.05M	Sell	3,918 -400	-9%	-$285K	0.22%	8
2023 Q4	$2.52M	Hold	4,318	–	–	0.18%	10
2023 Q3	$2.32M	Hold	4,318	–	–	0.29%	10
2023 Q2	$2.03M	Hold	4,318	–	–	0.26%	10
2023 Q1	$1.48M	Hold	4,318	–	–	0.21%	14
2022 Q4	$1.58M	Hold	4,318	–	–	0.26%	13
2022 Q3	$1.4M	Buy	4,318 +13	+0.3%	+$4.12K	2.23%	14
2022 Q2	$1.39M	Buy	4,305 +13	+0.3%	+$3.9K	0.18%	11
2022 Q1	$1.3M	Buy	4,292 +15	+0.4%	+$3.86K	1.85%	13
2021 Q4	$1.18M	Buy	+4,277	New	+$1.08M	0.08%	27

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lattice Capital Management's LLY Position: Q1 2026 in Review

Lattice Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,218 shares — an estimated $1.31M sold.

Lattice Capital Management first reported a position in LLY in Q4 2021 and held it in 15 quarters. The position peaked at $3.05M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Lattice Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Lattice Capital Management sold 1,218 Eli Lilly shares in Q1 2026, an estimated $1.31M.
Lattice Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 15 quarters.
Lattice Capital Management's Eli Lilly position peaked at $3.05M in Q1 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lattice Capital Management's 13F filing for Q1 2026, filed 15 May 2026.